Company intelligence / Profile preview

Yuva Biosciences

Birmingham, Alabama, United Statesx.com ↗

Ownership: Private
Employees: ~9
Development stage: Other

Overview

Yuva Biosciences has developed topical cosmeceuticals targeting hair loss and skin aging, leveraging mitochondrial science. The company is also advancing pharmaceutical candidates for metabolic and age-related conditions, including through partnerships. Patent filings indicate ongoing R&D in rare diseases and COVID-related applications.

Therapeutic areas: DermatologyMetabolic DisordersEndocrinology
Modalities: Small moleculeCosmeceutical (topical products)Pharmaceutical (drug development)
Industry: Biotech

Partnerships

Northstrive Biosciences Inc. (for obesity/type II diabetes drug development using Mitonova platform)Elevai Labs/Elevai Skincare Inc. (“combination patents” for breakthrough scalp/hair care technology using YuvaBio-Y100 innovation)

Beyond the preview

Go deeper on Yuva Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yuva Biosciences.

Explore the full profile